Nektar Therapeutics (NKTR): Price and Financial Metrics

NKTR POWR Grades

• NKTR scores best on the Quality dimension, with a Quality rank ahead of 77.49% of US stocks.
• The strongest trend for NKTR is in Growth, which has been heading down over the past 167 days.
• NKTR ranks lowest in Momentum; there it ranks in the 6th percentile.

NKTR Stock Summary

• NKTR's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.91 -- higher than just 11.87% of US-listed equities with positive expected earnings growth.
• Of note is the ratio of NEKTAR THERAPEUTICS's sales and general administrative expense to its total operating expenses; only 9.91% of US stocks have a lower such ratio.
• The volatility of NEKTAR THERAPEUTICS's share price is greater than that of 83.71% US stocks with at least 200 days of trading history.
• Stocks that are quantitatively similar to NKTR, based on their financial statements, market capitalization, and price volatility, are ABSI, XPER, AU, FF, and ILMN.
• Visit NKTR's SEC page to see the company's official filings. To visit the company's web site, go to www.nektar.com.

NKTR Valuation Summary

• In comparison to the median Healthcare stock, NKTR's price/sales ratio is 71.05% lower, now standing at 1.1.
• Over the past 243 months, NKTR's EV/EBIT ratio has gone up 16.8.

Below are key valuation metrics over time for NKTR.

NKTR Growth Metrics

Its 3 year revenue growth rate is now at -91.29%.
• The 4 year price growth rate now stands at 9.49%.
• The 2 year net income to common stockholders growth rate now stands at -6.61%.

NKTR's revenue has moved down $19,576,000 over the prior 33 months.

The table below shows NKTR's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	95.041	-397.842	-454.155
2022-06-30	96.337	-416.091	-524.812
2022-03-31	103.082	-423.999	-491.263
2021-12-31	101.907	-412.66	-523.837
2021-09-30	100.36	-359.756	-495.395
2021-06-30	105.472	-311.295	-474.275

NKTR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• NKTR has a Quality Grade of C, ranking ahead of 63.19% of graded US stocks.
• NKTR's asset turnover comes in at 0.072 -- ranking 285th of 682 Pharmaceutical Products stocks.
• CALA, ACOR, and CGEN are the stocks whose asset turnover ratios are most correlated with NKTR.

The table below shows NKTR's key quality metrics over time.